Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$106,198,119
+$62,408,332 QoQ
Shares Held
5,076,392
+2.7% QoQ
Ownership
3.51%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 99.99428728120286.ToString("F0")%
Shared 0.ToString("F0")%
None 0.00571271879712993.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. TNGX ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in TNGX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,198,119 | 5,076,392 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $43,789,787 | 4,942,414 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $12,679,590 | 1,509,475 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $553,875 | 108,179 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $236,232 | 172,433 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,504,483 | 486,888 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $4,184,926 | 543,497 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,275,996 | 614,918 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,872,793 | 613,702 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,447,228 | 449,215 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,293,323 | 114,860 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $300,682 | 90,567 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $320,577 | 81,159 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $507,746 | 70,034 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $994,000 | 274,586 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $364,189 | 80,395 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $771,537 | 101,786 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $903,709 | 82,606 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||